10-Q/A XBRL

10-Q/A

Company: Karyopharm Therapeutics Inc.
Filed: December 23, 2013
Period of Report: October 30, 2013
Accession Number: 0001104659-13-091964

View Document ↗ View on SEC.gov ↗